da Cruz Almeida Erika Tayse, da Silva Maria Cristina Delgado, Oliveira José Marcos Dos Santos, Kamiya Regianne Umeko, Arruda Rodolfo Elleson Dos Santos, Vieira Danilo Abreu, Silva Valdemir da Costa, Escodro Pierre Barnabé, Basílio-Júnior Irinaldo Diniz, do Nascimento Ticiano Gomes
Laboratório de Controle de Qualidade e Análise de Fármacos, Medicamentos e Alimentos, Curso de Farmácia, Escola de Enfermagem e Farmácia, Universidade Federal de Alagoas, Campus A.C. Simões, BR 104 Norte - Km 97, Maceió, AL. CEP:57072-970, Brazil.
Laboratório de Controle de Qualidade Microbiológico de Alimentos, Faculdade de Nutrição, Universidade Federal de Alagoas, Campus A.C. Simões, BR 104 Norte/Km 97, Maceió, AL. CEP:57072-970, Brazil.
J Pharm Anal. 2017 Oct;7(5):280-287. doi: 10.1016/j.jpha.2017.03.004. Epub 2017 Mar 18.
The aim of this study was to characterize tinctures and microcapsules loaded with an ethanol extract of red propolis through chemical, physicochemical and microbiological assays in order to establish quality control tools for nutraceutical preparations of red propolis. The markers (isoflavonoids, chalcones, pterocarpans, flavones, phenolic acids, terpenes and guttiferones) present in the tinctures A and B were identified and confirmed using LC/ESI/FTMS/Orbitrap. Four compositions (A, B, C and D) were prepared to contain B tincture of the red propolis with some pharmaceutical excipients and submitted to two drying processes, i. e. spray-drying and freeze-drying to obtain microcapsules loaded with the red propolis extract. The tinctures and microcapsules of the red propolis were submitted to the total flavonoid content and antioxidant activity tests. The antibacterial activity and minimum inhibitory concentration (MIC) were tested using ATCC 25293 and ATCC 27853 strains. The tinctures and microcapsules presented high flavonoid quantities from 20.50 to 40.79 mg/100 mg of the microcapsules. The antioxidant activity and IC were determined for the tinctures A and B (IC: 6.95 µg/mL and 7.48 µg/mL), the spray-dried microcapsules (IC50: 8.89-15.63 µg/mL) and the freeze-dried microcapsules (IC50: 11.83-23.36 µg/mL). The tinctures and microcapsules were proved to be bioactive against gram-positive and gram-negative bacteria with inhibition halos superior to 10 mm at concentration of 200 µg/mL and MIC values of 135.87-271.74 µg/mL using gram-positive strain and 271.74-543.48 µg/mL using gram-negative strain. The tinctures and microcapsules of the red propolis have a potential application for nutraceutical products.
本研究的目的是通过化学、物理化学和微生物学分析对负载红蜂胶乙醇提取物的酊剂和微胶囊进行表征,以便为红蜂胶的营养制剂建立质量控制工具。使用LC/ESI/FTMS/Orbitrap对酊剂A和B中存在的标志物(异黄酮、查耳酮、紫檀烷、黄酮、酚酸、萜类和藤黄烷酮)进行了鉴定和确认。制备了四种组合物(A、B、C和D),使其含有红蜂胶的B酊剂和一些药用辅料,并进行两种干燥工艺,即喷雾干燥和冷冻干燥,以获得负载红蜂胶提取物的微胶囊。对红蜂胶的酊剂和微胶囊进行了总黄酮含量和抗氧化活性测试。使用ATCC 25293和ATCC 27853菌株测试了抗菌活性和最低抑菌浓度(MIC)。酊剂和微胶囊的黄酮含量很高,微胶囊中每100毫克含有20.50至40.79毫克。测定了酊剂A和B的抗氧化活性和IC(IC:6.95微克/毫升和7.48微克/毫升)、喷雾干燥微胶囊(IC50:8.89 - 15.63微克/毫升)和冷冻干燥微胶囊(IC50:11.83 - 23.36微克/毫升)。已证明酊剂和微胶囊对革兰氏阳性菌和革兰氏阴性菌具有生物活性,在200微克/毫升的浓度下,抑菌圈大于10毫米,使用革兰氏阳性菌株时MIC值为135.87 - 271.74微克/毫升,使用革兰氏阴性菌株时MIC值为271.74 - 543.48微克/毫升。红蜂胶的酊剂和微胶囊在营养产品方面具有潜在应用价值。